$21.75 0.14 (+0.65%)
11/25/2009 4:00 PM

Pharmaceutical Product Development, Inc. (PPDI)

CAPS Rating: 5 out of 5

The Company is a global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs.

Results 1 - 20 of 74 1 2 3 4 Next »

Recs

0
Member Avatar newj101 (93.98) Submitted: 11/11/2009 10:58:59 AM : Outperform Start Price: $19.50 PPDI Score: -0.49

Only 1 negative quarter in 12 and this stock is cheap
The major players pipelines need to be filled and they will soon be throwing the money at development

Recs

0
Member Avatar Pumpstick (99.72) Submitted: 11/9/2009 3:13:26 PM : Outperform Start Price: $20.89 PPDI Score: +2.29

Yes!

Recs

0
Member Avatar Bigstu52 (57.18) Submitted: 11/7/2009 6:22:36 PM : Outperform Start Price: $20.81 PPDI Score: +1.37

strategic partnership in china, no debt, good dividend... upbeat conference call

Recs

0
Member Avatar wooderino (89.91) Submitted: 10/27/2009 12:15:50 PM : Outperform Start Price: $23.29 PPDI Score: -10.63

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Recs

0
Member Avatar ObscuredVision (52.68) Submitted: 10/23/2009 5:29:41 PM : Outperform Start Price: $23.05 PPDI Score: -8.78

Outsourcing will grow, Strong Financials, Leader in its field - Hold.

Recs

0
Member Avatar OutofDate1980 (< 20) Submitted: 9/24/2009 3:51:59 AM : Outperform Start Price: $21.85 PPDI Score: -4.92

Just numbers PEG TT&FETM (Trailing 2 & Future Estimate 2 months of 1.35. Then again the mechanics of valuation escape me.

Recs

0
Member Avatar DarkOblivion000 (42.91) Submitted: 9/16/2009 9:58:22 PM : Outperform Start Price: $22.21 PPDI Score: -6.50

Very steady and stable financials. P/E ratio very far below industry average, good dividend. Good stable industry that will be there forever.

Seems very cheap compared to 52 week high. I say good for growth over the next year or so as the economy recovers.

Recs

0
Member Avatar 08PortfolioModel (< 20) Submitted: 9/15/2009 1:03:25 PM : Outperform Start Price: $20.76 PPDI Score: +3.78

Current 21.71, Sept 15 09. Limit 20.10

Recs

0
Member Avatar gbetter (< 20) Submitted: 9/10/2009 10:29:42 AM : Outperform Start Price: $20.85 PPDI Score: -3.71

Skepticism on the stock is out of proportion to its long-term profit generating ability; it has industry leading margins, very strong BS, and outsourcing to CROs is increasing from Big Pharma.

Recs

0
Member Avatar CatFoodMoney (77.61) Submitted: 9/7/2009 9:04:34 PM : Outperform Start Price: $20.09 PPDI Score: -0.37

no matter what the economy does, you gotta have your meds

Recs

0
Member Avatar mmwmmr (22.62) Submitted: 9/4/2009 5:40:27 PM : Outperform Start Price: $20.09 PPDI Score: -0.37

Tracking the Royce Special Equity Fund.

Recs

0
Member Avatar 5SsmallcapDIV (69.36) Submitted: 9/2/2009 3:55:38 PM : Outperform Start Price: $19.68 PPDI Score: -1.28

5 Star, Small Cap- pays dividend

Recs

0
Member Avatar huddaman (94.73) Submitted: 8/26/2009 10:50:19 PM : Outperform Start Price: $21.99 PPDI Score: -47.78

This one is extremely attractive stock with great entry point at this price. I think it has lot of downside protection, but at the same time tremendous upside. By the time next real bull market arrives, this one will be $65-$70

Recs

0
Member Avatar ChimneyRock (< 20) Submitted: 8/25/2009 11:30:17 PM : Outperform Start Price: $19.83 PPDI Score: +0.05

5-Star, good financials

Recs

0
Member Avatar MFddunaier (68.93) Submitted: 8/7/2009 11:29:30 AM : Outperform Start Price: $20.56 PPDI Score: -4.47

Great upside, value has been beaten down

Recs

0
Member Avatar Ak66 (81.40) Submitted: 8/1/2009 11:51:33 PM : Outperform Start Price: $20.78 PPDI Score: -7.40

Decent stock (not great) that is trading below its value. It has much larger upside.

Recs

0
Member Avatar HankSilvers95 (44.24) Submitted: 7/25/2009 12:20:24 PM : Outperform Start Price: $19.85 PPDI Score: -4.76

Me, I'm just following the crowd. A lot of smart people recommended it, and who am I to argue with success?

Recs

0
Member Avatar TMFBiologyFool (92.02) Submitted: 7/22/2009 11:26:16 PM : Outperform Start Price: $18.95 PPDI Score: -2.26

Outsourcing R&D will pick up again.

Recs

0
Member Avatar TMFHelical (98.19) Submitted: 7/22/2009 8:57:09 AM : Outperform Start Price: $19.34 PPDI Score: -4.42

Very well run CRO struggling through industry consolidation and funding issues. Outsourcing is still a trend embraced by pharma development and growth will return here.

Recs

0
Member Avatar freeits (99.72) Submitted: 7/9/2009 6:04:43 PM : Outperform Start Price: $21.16 PPDI Score: -24.80

Someone on CAPS made an indepth report about this company's performance over the past 36 months. I did not understand most of his anaylsis, but others complemented him on his words of wisdom.

Seeing that a "Wise Old Fool" her on CAPS states that this will outpeform, I must agree with this, as the "Young Wipper Snapper Idiots" on CAPS got not a clue.

Results 1 - 20 of 74 1 2 3 4 Next »

Featured Broker Partners